Bloomberg Quint
By Sarah McBride
03:30 PM IST, 04 May 2022 04:44 PM IST, 04 May 2022
(Bloomberg) — Synchron Inc., which develops a so-called brain-computer interface and competes with Elon Musk’s Neuralink Corp., enrolled the first patient in its U.S. clinical trial, putting the company’s implant on a path toward possible regulatory approval for wider use in people with paralysis. The early feasibility study is funded by the National Institutes of Health and will evaluate the safety of the device…
Read more…